BOSTON SCIENTIFIC CORPORATION Other Significant Noncash Transaction, Value of Consideration Given
BOSTON SCIENTIFIC CORPORATION (BSX) reported Other Significant Noncash Transaction, Value of Consideration Given of $72.00 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1 · last filed 2020-02-25
- BOSTON SCIENTIFIC CORPORATION other significant noncash transaction, value of consideration given for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION other significant noncash transaction, value of consideration given for the quarter ending 2014-03-31 was $3.00M.
- BOSTON SCIENTIFIC CORPORATION other significant noncash transaction, value of consideration given for fiscal 2019 was $72.00M, a 0.00% change from fiscal 2018.
- BOSTON SCIENTIFIC CORPORATION other significant noncash transaction, value of consideration given for fiscal 2018 was $72.00M, a 23.40% decline from fiscal 2017.
- BOSTON SCIENTIFIC CORPORATION other significant noncash transaction, value of consideration given for fiscal 2017 was $94.00M, a 88.00% increase from fiscal 2016.
- BOSTON SCIENTIFIC CORPORATION other significant noncash transaction, value of consideration given for fiscal 2016 was $50.00M, a 20.63% decline from fiscal 2015.
| Period end | Other Significant Noncash Transaction, Value of Consideration Given 3 month | Other Significant Noncash Transaction, Value of Consideration Given 12 month | Other Significant Noncash Transaction, Value of Consideration Given 12 month as first filed |
|---|---|---|---|
| 2019-12-31 | $72.00M 10-K · filed 2020-02-25 | ||
| 2018-12-31 | $72.00M 10-K · filed 2019-02-19 | ||
| 2017-12-31 | $94.00M 10-K · filed 2018-02-20 | ||
| 2016-12-31 | $50.00M 10-K · filed 2018-02-20 | ||
| 2015-12-31 | $63.00M 10-K · filed 2018-02-20 | ||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-06 | ||
| 2014-12-31 | $3.00M 10-K · filed 2017-02-23 | ||
| 2014-03-31 | $3.00M 10-Q · filed 2015-05-06 | ||
| 2013-12-31 | $0.00 10-K · filed 2016-02-24 | ||
| 2012-12-31 | $467.00M 10-K · filed 2015-02-25 | $465.00M 10-K · filed 2013-02-22 | |
| 2011-12-31 | $287.00M 10-K · filed 2014-02-26 | ||
| 2010-12-31 | $69.00M 8-K · filed 2013-05-29 | $75.00M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |